Results 21 to 30 of about 14,538,270 (379)
The Journal of Haemophilia Practice, 2021 Current treatment for severe haemophilia includes prophylactic factor replacement to prevent bleeding. Coagulation factor products have significant inter-patient variability in pharmacokinetic (PK) parameters.
Kwan Celia +5 more
doaj +1 more source
Realistic Calculation of the hep Astrophysical Factor [PDF]
, 2000 The astrophysical factor for the proton weak capture on 3He is calculated with correlated-hyperspherical-harmonics bound and continuum wave functions corresponding to a realistic Hamiltonian consisting of the Argonne v18 two-nucleon and Urbana-IX three ...
A. E. Cox +36 more
core +3 more sources
Center-of-mass corrections revisited: a many-body expansion approach [PDF]
, 1998 A many-body expansion for the computation of the charge form factor in the center-of-mass system is proposed. For convergence testing purposes, we apply our formalism to the case of the harmonic oscillator shell model, where an exact solution exists.
Heisenberg, Jochen H., Mihaila, Bogdan
core +2 more sources
Seroprevalence of Hepatitis B and Hepatitis C in People with Haemophilia at a Tertiary Care Centre, Assam, India: A Cross-sectional Study [PDF]
Journal of Clinical and Diagnostic ResearchIntroduction: Prior to the advent of recombinant factor products, the treatment of haemophilia was mainly based on the administration of direct blood products like whole blood, Fresh Frozen Plasma (FFP), and cryoprecipitates. This led to a high incidence
Anupam Dutta +2 more
doaj +1 more source
Turkish Journal of Hematology, 2014 OBJECTIVE: Hemophilia B is caused by coagulation defects in the factor IX gene located in Xq27.1 on the X chromosome. A wide range of mutations, showing extensive molecular heterogeneity, have been described in hemophilia B patients.
Dong Hua Cao +7 more
doaj +1 more source
Reports, 2020 This study aimed to identify the characteristics of patients with hemophilia B eligible for once-weekly treatment with Nonacog alfa. Methods: A survey was conducted in 14 Hemophilia (HCs) of Italy.
Dorina Cultrera +14 more
doaj +1 more source
Ion Exchange-Precipitation for Nutrient Recovery from Dilute Wastewater [PDF]
, 2015 Regulated phosphorus (P) and nitrogen (N) discharges and the cost of fertilizer provide economic drivers for nutrient removal and recovery from wastewater.
Mayer, Brooke K. +2 more
core +2 more sources
RENAL ALLOGENEIC TRANSPLANTATION IN PATIENT WITH HAEMOPHILIA B
Вестник трансплантологии и искусственных органов, 2014 We report the case of successful renal allogeneic transplantation and treatment in a 56-year-old patient with haemophilia B at Hematology Research Center. He has received replacement therapy by factor IX since 2010.
N. V. Purlo +4 more
doaj +1 more source
Factor IX p.A37V mutation causes severe bleeding in a patient with phenprocoumon therapy
European Journal of Medical Research, 2021 Background Bleeding is the most common complication of oral anticoagulants, due to inadequate dosing. Case presentation This report describes the clinical course of a patient who developed severe bleeding under therapy with phenprocoumon, despite an INR ...
Nils Mülling +3 more
doaj +1 more source
EMBO Molecular Medicine, 2016 The X‐linked genetic bleeding disorder caused by deficiency of coagulator factor IX, hemophilia B, is a disease ideally suited for gene therapy with genome editing technology. Here, we identify a family with hemophilia B carrying a novel mutation, Y371D,
Yuting Guan +17 more
semanticscholar +1 more source